Mirena® (Levonorgestrel intrauterine system): A successful novel drug delivery option in contraception
Authors:
- Susan RoseSRSusan Rose
- Angela ChaudhariACAngela Chaudhari
- C. Matthew PetersonCPC. Matthew Peterson
- 1 August 2009
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 61 (10) , 808-812
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Can the levonorgestrel intrauterine system replace surgical treatment for the management of menorrhagia?BJOG: An International Journal of Obstetrics & Gynaecology, 2002
- Progestin-Releasing Intrauterine SystemsSeminars in Reproductive Medicine, 2001
- Levonorgestrel‐releasing (20 μg/day) intrauterine systems (Mirena) compared with other methods of reversible contraceptivesBJOG: An International Journal of Obstetrics & Gynaecology, 2000
- Ovarian function after seven years' use of a levonorgestrel IUDAdvances in Contraception, 1995
- Return to fertility after removal of a levonorgestrel-releasing intrauterine device and Nova-TContraception, 1992
- Levonorgestrel-Releasing Intrauterine DeviceAnnals of Medicine, 1990
- TISSUE CONCENTRATIONS OF LEVONORGESTREL IN WOMEN USING A LEVONORGESTREL‐RELEASING IUDClinical Endocrinology, 1982
- INTRAUTERINE CONTRACEPTION WITH LEVONORGESTREL: A COMPARATIVE RANDOMISED CLINICAL PERFORMANCE STUDYThe Lancet, 1981
- Levonorgestrel plasma concentrations and hormone profiles after insertion and after one year of treatment with a levonorgestrel-IUDContraception, 1980
- Plasma levels of d-norgestrel, estradiol and progesterone during treatment with silastic implants containing d-norgestrelContraception, 1976